AccuraGen Appoints George Cardoza as Chief Executive Officer
July 24, 2022
George Cardoza will be joining AccuraGen as its Chief Executive Officer and will also be joining the Board of Directors.
The latest news
from architecture world.
Several Experts Highly Recognized AccuraGen's Scientific Research
September 18, 2020
Several experts highly recognized AccuraGen's scientific research on early cancer detection.
NGS Roundtable Forum: Opportunities and Challenges of NGS
September 11, 2020
Kang Ying, CEO of AccuraGen Holdings participated in NGS roundtable forum and shared his perspectives on cancer screening.
AccuraGen China passed the proficiency test of 2019-nCoV nucleic acid testing
April 9, 2020
AccuraGen China passed the proficiency test of 2019-nCoV nucleic acid testing (NCCL)
Collaborative research on early detection of colorectal cancer unveiled at AGBT
February 28, 2020
AccuraGen unveil edits result of the collaborative research on the early detection of colorectal cancer at AGBT this year.
AccuraGen China passed the PT of 2019-nCoV nucleic acid testing
February 25, 2020
Shanghai Yunsheng Medical Laboratory hasactively participated in the 2019-nCoV nucleic acid detection capabilityverification organized by SCCL.
AccuraGen China Participated in the Campaign against 2019-nCoV
February 3, 2020
Shanghai Yunsheng Medical Laboratory participated in the campaign against 2019-nCoV on February 2nd.
Collaborator Presented New Data at ESMO 2019 Congress
October 9, 2019
Dr. Tao Fu presented new data as a poster at the ESMO 2019 Congress.
Several Collaborator Presented Research Result of Different Cancers
September 5, 2019
Several Collaborator Presented Research Result of Different Cancers
Collaborator Presented Research Result on Small Methods Journal
August 30, 2019
Research result conducted by Professor Jiatao Lou recently published on Small Methods.
AccuraGen Sponsored the 8th Annual Meeting of Chinese Pathologists
October 17, 2018
AccuraGen sponsored the session of "Writing and Publication of English Papers on Pathology" at the 8th Annual Meeting of Chinese Pathologists.
AccuraGen Passed CAP NGSST-PT with Full Marks Again
July 19, 2018
The NGS laboratory under AccuraGen Holdings passed the NGSST Proficiency Testing assessment launched by CAP with full marks again.
Shanghai Yunsheng Medical Laboratory joined the Inclusive Medical Association
May 14, 2018
Shanghai Yunsheng Medical Laboratory under AccuraGen Holdings participated in the launch of the Inclusive Medical Association.
Collaborator presented AccuraGen's ctDNA-NGS kit validation at AACR
April 25, 2018
The study was conducted by Professor Jiatao Lou, director of the Chest Hospital.
AccuraGen Clinical Laboratory obtained CAP accreditation
March 5, 2018
The High-throughput Sequencing (NGS) Laboratory of AccuraGen Holdings Group has been accredited by the College of American Pathologists (CAP).
AccuraGen passed the EQA of bioinformatics with full score
January 29, 2018
Shanghai Yunsheng Medical Laboratory Co., Ltd., a subsidiary of AccuraGen Holdings, passed the external quality evaluation with 100 marks.
AccuraGen was invited to PMWC to showcase the latest achievements in liquid biopsy
January 29, 2018
The Precision Medicine World Conference (PMWC) of 2018 was held in Silicon Valley from January 22 to 24 in the United States.